SUMMARY OBJECTIVE: We investigated surgical complications of elective surgery for diverticulitis in international multi-institution to identify a prediction model for potential opportunities of quality improvement. METHODS: We identified 1225 patients who underwent elective surgery for diverticulitis between January 2010 and January 2018. The data were obtained from the National Surgical Quality Improvement Program and the Turkish Diverticulitis Study Group Collaborative, retrospectively. RESULTS: We observed that the presence of chronic obstructive pulmonary disease (OR: 3.2, 95%CI 1.8–5.9, p<0.001) or abscess at the time of surgery (OR: 1.4, 95%CI 1.2–1.7, p£0.001) is associated with a higher rate of minor complications, while comorbidities such as dyspnea (OR: 2.8, 95%CI 1.6–4.9, p£0.001) and preoperative sepsis (OR: 4.1, 95%CI 2.3–7.3, p£0.001) are associated with major complications. The centers had similar findings in minor and major complications (OR: 0.8, 95%CI 0.5–1.4, p=0.395). The major independent predictors for complications were malnutrition (low albumin) (OR: 0.5, 95%CI 0.4–0.6, p<0.001) and the American Society of Anesthesiology score (OR: 1.7, 95%CI 1.2–2.4, p=0.002). CONCLUSION: Regarding the major and minor complications of diverticulitis of elective surgery, the malnutrition and higher American Society of Anesthesiology score showed higher impact among the quality improvement initiatives.

Resumen Objetivo: Aunque el reingreso hospitalario posterior a la cirugía se reconoció como un problema nuevo, su asociación con la colecistectomía no ha sido resuelta. Nuestro objetivo fue investigar la tasa de reingreso al hospital no planificado después de la colecistectomía y evaluar las razones y los resultados en estos pacientes. Métodos: Todos los pacientes consecutivos que se sometieron a colecistectomía abierta y laparoscópica fueron evaluados retrospectivamente. Se investigó el reingreso al hospital dentro de los primeros 90 días postoperatorios. La tasa y las razones de la readmisión hospitalaria fueron los resultados primarios. Resultados: Se examinaron 601 pacientes con una edad media de 53.2 ± 12.4 años. La tasa de reingreso fue del 6.16%. Obesidad (p = 0.001), número de enfermedades coexistentes (p = 0.039), conversión a cirugía abierta (p = 0.002), desarrollo de complicaciones intraoperatorias (p < 0.001), uso de drenaje (p = 0.001) y longitud de estancia hospitalaria > 1 día (p = 0.024) se asociaron significativamente con tasas más altas de reingreso. Se detectaron causas quirúrgicas biliares en cinco pacientes (12.8%). Se observaron causas quirúrgicas no biliares en 34 pacientes (87.2%). Entre estos, el dolor postoperatorio, las náuseas y los vómitos fueron los diagnósticos más comunes en 25 (67.6%) y 5 pacientes (12.8%). Conclusión: La tasa de reingreso después de la colecistectomía es baja. Factores predictivos significativos pueden ayudar a los médicos a estar alertas durante el alta de los pacientes. El dolor postoperatorio, las náuseas y los vómitos fueron los diagnósticos más frecuentes.

Abstract Objective: Although readmission after surgical procedures has been recognized as a new problem, its association with cholecystectomy has not been solved. We aimed to investigate the rate of unplanned readmission after cholecystectomy and to evaluate the reasons and outcomes in these patients. Methods: All consecutive patients who underwent open and laparoscopic cholecystectomy were retrospectively evaluated. Hospital readmission within the post-operative first 90 days after the procedure was searched. The rate and reasons for hospital readmission were the primary outcomes. Results: There were 601 patients with a mean age of 53.2 ± 12.4 years. The rate of readmission was 6.16%. Obesity (p = 0.001), number of coexisting disease (p = 0.039), conversion to open surgery (p = 0.002), development of intraoperative complications (p < 0.001), use of drain (p = 0.001), and length of hospital stay > 1 day (p = 0.024) were significantly associated with higher readmission rates. Biliary surgical causes were detected in five patients (12.8%). Non-biliary surgical causes were seen in 34 patients (87.2%). Among these, post-operative pain, nausea, and vomiting were the most common diagnoses in 25 (67.6%) and 5 patients (12.8%). Conclusion: The readmission rate after cholecystectomy is low. Significant predictive factors may help physicians to be alerted during the discharge of the patients. Post-operative pain, nausea, and vomiting were the most common diagnoses.

ABSTRACT Purpose To investigate the efficacy of cordycepin, an adenosine analogue, on prevention of esophageal damage and stricture formation due to esophageal caustic burns in rat model comparing with prednisolone. Methods Caustic esophageal burn was introduced by 37.5% of NaOH to distal esophagus. Thirty-two Wistar albino rats were divided in four groups: sham rats undergone laparotomy, treated with 0.9% NaCl; control rats injured with NaOH without cordycepin treatment; cordycepin group injured with NaOH, treated with 20 mg/kg cordycepin; prednisolone group injured with NaOH, treated with 1 mg/kg prednisolone for 28 days. Efficacy was assessed by histopathological and immunohistochemical analysis of esophageal tissues. Results Cordycepin treatment significantly decreased inflammation, granulation tissue and fibrous tissue formation and prevented formation of esophageal strictures shown by histopathological damage score and stenosis indexes compared to control group (p < 0.01). These effects are relatively more substantial than prednisolone, probably based on attenuation of elevation of proinflammatory cytokines hypoxia-inducible factor 1-alpha (HIF-1?), tumor necrosis factor alpha (TNF-?), proliferative and fibrotic factor fibroblast growth factor 2 (FGF2) and angiogenic factor vascular endothelial growth factor A (VEGFA) (p < 0.05). Conclusions The findings suggest that cordycepin has a complex multifactorial healing process in alkali-burned tissue, more successful than prednisolone in preventing the formation of esophageal strictures and may be used as a therapeutic agent in the acute phase of esophageal alkali-burn.